1. Home
  2. SNCR vs ANVS Comparison

SNCR vs ANVS Comparison

Compare SNCR & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synchronoss Technologies Inc.

SNCR

Synchronoss Technologies Inc.

HOLD

Current Price

$8.68

Market Cap

59.5M

Sector

Technology

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$4.07

Market Cap

111.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNCR
ANVS
Founded
2000
2008
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
111.3M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
SNCR
ANVS
Price
$8.68
$4.07
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$13.50
AVG Volume (30 Days)
167.6K
606.4K
Earning Date
11-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$170,909,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.07
N/A
52 Week Low
$3.98
$1.11
52 Week High
$12.85
$5.57

Technical Indicators

Market Signals
Indicator
SNCR
ANVS
Relative Strength Index (RSI) 76.22 57.45
Support Level $8.53 $3.26
Resistance Level $8.50 $3.72
Average True Range (ATR) 0.12 0.26
MACD -0.10 -0.01
Stochastic Oscillator 95.83 90.99

Price Performance

Historical Comparison
SNCR
ANVS

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Share on Social Networks: